Vinva Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.1M Buy
71,848
+18,327
+34% +$6.53M 0.31% 87
2025
Q4
$17.6M Buy
53,521
+8,613
+19% +$2.73M 0.22% 115
2025
Q3
$12.3M Buy
44,908
+7,958
+22% +$2.31M 0.24% 104
2025
Q2
$10.2M Buy
36,950
+9,178
+33% +$2.6M 0.27% 95
2025
Q1
$8.52M Buy
27,772
+1,250
+5% +$369K 0.34% 69
2024
Q4
$6.88M Buy
26,522
+4,909
+23% +$1.46M 0.26% 88
2024
Q3
$6.97M Buy
21,613
+7,264
+51% +$2.38M 0.29% 85
2024
Q2
$4.5M Buy
14,349
+3,497
+32% +$1.03M 0.23% 112
2024
Q1
$3.09M Sell
10,852
-7,607
-41% -$2.23M 0.17% 145
2023
Q4
$5.32M Buy
18,459
+2,671
+17% +$728K 0.36% 68
2023
Q3
$4.28M Sell
15,788
-11
-0.1% -$2.75K 0.4% 58
2023
Q2
$3.49M Sell
15,799
-2,274
-13% -$528K 0.3% 79
2023
Q1
$4.36M Buy
+18,073
New +$4.44M 0.36% 69

Other funds holding AMGN

Vinva Investment Management's AMGN Position: Q1 2026 in Review

Vinva Investment Management increased its Amgen (AMGN) stake by 34% in Q1 2026, buying an estimated $6.53M and bringing the position to 71,848 shares worth $25.1M. The position accounts for 0.31% of the portfolio, ranked #87.

Vinva Investment Management first reported a position in AMGN in Q1 2023 and has held it in 13 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Vinva Investment Management held 71,848 shares of Amgen worth $25.1M as of Q1 2026.
  • Vinva Investment Management bought 18,327 Amgen shares in Q1 2026, an estimated $6.53M.
  • Amgen made up 0.31% of Vinva Investment Management's portfolio in Q1 2026, its #87 holding.
  • Vinva Investment Management first reported a position in Amgen in Q1 2023 and has held it in 13 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.